MetaStat Inc (MTST):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MetaStat Inc (MTST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8085
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable targets. It offers products such as MetaSite Breast, an immunohistochemistry-based assay developed to predict the spread of cancer through the bloodstream to other organs; and MenaCalc Lung, a test evaluated to predict the likelihood of metastasis in adenocarcinoma of the lung. MetaStat’s technologies are based on identification of a pathway for developing metastatic disease in solid epithelial-based tumors. The company develops its products using mena protein, a potentiator and modulator of cellular migration. MetaStat is headquartered in Boston, Massachusetts, the US.

MetaStat Inc (MTST) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MetaStat Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MetaStat Inc, Medical Devices Deals, 2012 to YTD 2018 9
MetaStat Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MetaStat Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 11
Licensing Agreements 12
MetaStat Amends Licensing Agreement with Celgene 12
ASET Therapeutics Enters into Licensing Agreement with MetaStat 13
MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 15
Equity Offering 17
MetaStat Raises USD0.4 Million in Second Tranche of Private Placement of Shares and Preferred Shares 17
MetaStat Raises USD2.1 Million in First Tranche of Private Placement of Shares and Preferred Shares 18
MetaStat Completes First Tranche of Private Placement of Units 19
MetaStat Raises USD2.1 Million in Final Tranche of Private Placement of Series B Preferred Shares 20
MetaStat Completes Private Placement Of Shares For US$0.81 Million 22
Debt Offering 23
MetaStat Raises USD3.6 Million in Private Placement of 10% Notes Due 2018 23
Acquisition 24
PhotoVoltaic Solar Cells Acquires MetaStat, Life Science Company 24
MetaStat Inc – Key Competitors 25
MetaStat Inc – Key Employees 26
MetaStat Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Corporate Communications 28
Aug 03, 2017: MetaStat Welcomes Renato T. Skerlj, Ph.D., Accomplished Drug Developer to Its Scientific and Clinical Advisory Board 28
May 08, 2017: MetaStat Elevates Jerome B. Zeldis, M.D., Ph.D. to Chairman of the Board and Appoints Douglas A. Hamilton, MetaStat’s President and CEO to its Board of Directors 29
Product News 30
04/06/2017: Mena Expression is Associated with Paclitaxel-mediated Increase in Cancer Cell Dissemination 30
Clinical Trials 31
Jun 21, 2018: MetaStat Presents Positive Data Showing Inhibition of the MENA-pathway Reduces Cancer Cell Dissemination and Paclitaxel Resistance in Aggressive Cancer 31
Feb 28, 2018: MetaStat Announces Positive Topline Data Showing Over 50% Reduction in Cancer Metastasis from Preclinical Studies Evaluating Inhibition of the MAPKAPK2 Kinase Pathway 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
MetaStat Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MetaStat Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MetaStat Inc, Deals By Therapy Area, 2012 to YTD 2018 8
MetaStat Inc, Medical Devices Deals, 2012 to YTD 2018 9
MetaStat Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 11
MetaStat Amends Licensing Agreement with Celgene 12
ASET Therapeutics Enters into Licensing Agreement with MetaStat 13
MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 15
MetaStat Raises USD0.4 Million in Second Tranche of Private Placement of Shares and Preferred Shares 17
MetaStat Raises USD2.1 Million in First Tranche of Private Placement of Shares and Preferred Shares 18
MetaStat Completes First Tranche of Private Placement of Units 19
MetaStat Raises USD2.1 Million in Final Tranche of Private Placement of Series B Preferred Shares 20
MetaStat Completes Private Placement Of Shares For US$0.81 Million 22
MetaStat Raises USD3.6 Million in Private Placement of 10% Notes Due 2018 23
PhotoVoltaic Solar Cells Acquires MetaStat, Life Science Company 24
MetaStat Inc, Key Competitors 25
MetaStat Inc, Key Employees 26
MetaStat Inc, Other Locations 27

List of Figures
MetaStat Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MetaStat Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MetaStat Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[MetaStat Inc (MTST):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Admedus Ltd (AHZ):製品パイプライン分析
    Summary Admedus Ltd (Admedus) develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies. Using its proprietary ADAPT engineering process, the company is developing a group of regenerative tissue bio-scaffolds for use in soft tissue r …
  • Itochu Chemical Frontier Corp-製薬・医療分野:企業M&A・提携分析
    Summary Itochu Chemical Frontier Corp (ICF), formerly Ando Kaseihin KK, a subsidiary of Itochu Corporation, is a chemical company that manufactures and markets chemical products. The company operates in intermediate chemical division, silicone and adhesive division, osaka and nagoya division, perfor …
  • Family Dollar Stores, Inc.:企業の戦略・SWOT・財務情報
    Family Dollar Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Family Dollar Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Gibson Energy Inc (GEI):石油・ガス:M&Aディール及び事業提携情報
    Summary Gibson Energy Inc (Gibson) is an independent midstream energy company. It provides integrated services to the oil and gas industry. The company transport, store, blend, process, market and distribute crude oil, condensate, natural gas liquids, water, oilfield waste, and refined products. Gib …
  • Oriental Hotels Ltd:戦略・SWOT・企業財務分析
    Oriental Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Oriental Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • VolitionRX Ltd (VNRX):製薬・医療:M&Aディール及び事業提携情報
    Summary VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of va …
  • Goldman Sachs Private Wealth Management:企業の戦略・SWOT・財務情報
    Goldman Sachs Private Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Goldman Sachs Private Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Sunquest Information Systems Inc:企業の戦略的SWOT分析
    Sunquest Information Systems Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Hung Hing Printing Group Limited:企業の戦略・SWOT・財務情報
    Hung Hing Printing Group Limited - Strategy, SWOT and Corporate Finance Report Summary Hung Hing Printing Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • GS Retail Co., Ltd. (007070):企業の財務・戦略的SWOT分析
    GS Retail Co., Ltd. (007070) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Bandai Namco Holdings Inc. (7832):企業の財務・戦略的SWOT分析
    Bandai Namco Holdings Inc. (7832) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Compagnie de Saint-Gobain:企業のM&A・事業提携・投資動向
    Compagnie de Saint-Gobain - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Compagnie de Saint-Gobain Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Graham Holdings Company:企業の戦略・SWOT・財務分析
    Graham Holdings Company - Strategy, SWOT and Corporate Finance Report Summary Graham Holdings Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Walmart Chile S.A.:企業の戦略的SWOT分析
    Walmart Chile S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Mamee-Double Decker (M) Berhad:企業の戦略的SWOT分析
    Mamee-Double Decker (M) Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Shanxi Zhendong Pharmaceutical Co Ltd (300158):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanxi Zhendong Pharmaceutical Co Ltd (Zhendong Group) is a pharmaceutical company. The company researches, develops, manufactures and markets pharmaceutical products and Chinese medicines in China. It offers products such as cancer drugs, cardiovascular drugs, infectious disease drugs, resp …
  • Damodar Valley Corp:企業の戦略的SWOT分析
    Damodar Valley Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Panmure Gordon & Co Limited (PMR):企業の財務・戦略的SWOT分析
    Panmure Gordon & Co Limited (PMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Rubicon Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Rubicon Genomics Inc (Rubicon Genomics), a subsidiary of the Takara Bio Group is a provider of pre-analytical amplification technologies. The company offers various types of kits for whole genome sequencing (WGS), whole exome sequencing (WES), targeted sequencing, copy number variation (CNV) …
  • Illumina Inc (ILMN):企業の財務・戦略的SWOT分析
    Illumina Inc (ILMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆